Every record from Janoshik · page 27
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041558 | TB-500 | QYB | QYB-2511-H6699 | 2026-Q1 | 99.47 | 6.25 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041348 | CJC-1295 with DAC | WWB | WWB-2508-V3100 | 2026-Q1 | 99.39 | 6.15 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043123 | CJC-1295 with DAC | SSA | SSA-2512-C6732 | 2026-Q1 | 98.09 | 3.00 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042717 | Retatrutide | GGPeps | GGPE-2511-W9618 | 2026-Q1 | 97.84 | 6.74 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042611 | Semax | GGPeps | GGPE-2511-X8435 | 2026-Q1 | 98.20 | 7.62 | 95.0 | Buyer-sourced | 1 | FAIL |
| AX-2026-041634 | Semaglutide | QSC | QSC-2602-G8557 | 2026-Q1 | 99.05 | 5.13 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041228 | Tirzepatide | WWB | WWB-2511-J1983 | 2026-Q1 | 98.97 | 3.89 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043572 | Tirzepatide | BCH | BCH-2601-N7656 | 2026-Q1 | 97.24 | 4.33 | 101.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043491 | Leuprolide | WXT | WXT-2511-S5991 | 2026-Q1 | 98.44 | 5.53 | 97.4 | Supplier-supplied | 1 | FAIL |
| AX-2026-041780 | PT-141 (Bremelanotide) | FGP | FGP-2505-K1249 | 2025-Q4 | 99.24 | 3.61 | 90.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041301 | TB-500 | WWB | WWB-2601-E2735 | 2026-Q1 | 99.93 | 4.09 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042805 | MOTS-c | GGPeps | GGPE-2508-J1903 | 2025-Q4 | 98.74 | 4.68 | 100.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042605 | Semax | GGPeps | GGPE-2511-X8435 | 2026-Q1 | 98.76 | 7.38 | 100.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042423 | Selank | SWB | SWB-2511-C5170 | 2025-Q4 | 99.15 | 8.80 | 105.4 | Supplier-supplied | 0 | PASS |
| AX-2026-042281 | Tirzepatide | Homopeptide | HOMO-2509-U2115 | 2025-Q4 | 98.66 | 2.76 | 91.9 | Supplier-supplied | 2 | FAIL |
| AX-2026-041737 | Semaglutide | FGP | FGP-2506-J9812 | 2025-Q4 | 99.93 | 5.01 | 93.5 | Supplier-supplied | 0 | PASS |
| AX-2026-042793 | Thymulin | GGPeps | GGPE-2510-C1982 | 2026-Q1 | 98.35 | 2.31 | 91.4 | Supplier-supplied | 0 | PASS |
| AX-2026-042252 | Semaglutide | Homopeptide | HOMO-2509-F1941 | 2025-Q4 | 99.74 | 4.70 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041867 | GHRP-2 | JEEP | JEEP-2508-S3268 | 2025-Q4 | 99.93 | 3.77 | 90.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043307 | L-Glutathione (reduced) | CPC | CPC-2602-D2535 | 2026-Q1 | 98.16 | 7.72 | 106.0 | Supplier-supplied | 0 | FAIL |
| AX-2026-042533 | CJC-1295 (no DAC) | ERP | ERP-2506-B7535 | 2025-Q4 | 98.80 | 6.96 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042198 | Semaglutide | Homopeptide | HOMO-2511-C9607 | 2026-Q1 | 99.38 | 4.70 | 97.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041875 | SS-31 (Elamipretide) | JEEP | JEEP-2511-B3061 | 2025-Q4 | 99.10 | 5.11 | — | Supplier-supplied | 0 | PASS |
| AX-2026-043506 | Gonadorelin | BCH | BCH-2510-F6239 | 2025-Q4 | 98.08 | 5.44 | — | Buyer-sourced | 0 | FAIL |
| AX-2026-041649 | Tirzepatide | QSC | QSC-2510-D8660 | 2025-Q4 | 99.19 | 3.61 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041546 | IGF-1 LR3 | QYB | QYB-2512-Y6648 | 2026-Q1 | 98.65 | 6.24 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042573 | BPC-157 | ERP | ERP-2509-G8440 | 2026-Q1 | 98.76 | 3.42 | 91.4 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042001 | AOD-9604 | TFC | TFC-2511-L5476 | 2025-Q4 | 99.93 | 3.36 | 99.3 | Supplier-supplied | 0 | PASS |
| AX-2026-041736 | Semaglutide | FGP | FGP-2506-J9812 | 2025-Q4 | 99.93 | 5.01 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041437 | BPC-157 | QYB | QYB-2506-B4999 | 2025-Q4 | 99.93 | 4.57 | 102.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043328 | GHRP-6 | CPC | CPC-2507-G2066 | 2025-Q4 | 99.57 | 6.71 | 107.1 | Supplier-supplied | 3 | MARGINAL |
| AX-2026-042501 | CJC-1295 with DAC | ERP | ERP-2507-A6393 | 2025-Q4 | 99.93 | 3.29 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043264 | Selank | SGN | SGN-2508-Y1438 | 2026-Q1 | 98.94 | 6.49 | 98.7 | Supplier-supplied | 0 | FAIL |
| AX-2026-042691 | Sermorelin | GGPeps | GGPE-2508-U8736 | 2025-Q4 | 99.22 | 3.74 | 105.3 | Supplier-supplied | 0 | PASS |
| AX-2026-041738 | TB-500 | FGP | FGP-2508-S1106 | 2025-Q4 | 99.43 | 4.38 | 92.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042689 | CJC-1295 (no DAC) | GGPeps | GGPE-2507-D8658 | 2025-Q4 | 98.83 | 3.75 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041910 | BPC-157 | JEEP | JEEP-2505-J3812 | 2025-Q4 | 99.55 | 3.01 | 91.0 | Supplier-supplied | 0 | PASS |
| AX-2026-043199 | Semaglutide | GL Biochem | GLBI-2508-D8720 | 2025-Q4 | 98.77 | 4.15 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042791 | Cagrilintide | GGPeps | GGPE-2507-Y1706 | 2025-Q4 | 98.10 | 1.04 | 105.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042532 | CJC-1295 (no DAC) | ERP | ERP-2506-B7535 | 2025-Q4 | 98.67 | 5.67 | 90.1 | Buyer-sourced | 2 | MARGINAL |